Alzheimer’s Facts and Myths
- 20 July, 2017
With the internet, there is so much information that can be found about Alzheimer’s disease. While this is a huge advantage for the most part, sometimes the internet accidentally spreads false information about things including Alzheimer’s Disease. Below, we will discuss some of these ‘myths’ and clarify them for you.
Myth One: Alzheimer’s disease is not fatal
Fact: Alzheimer’s disease destroys the brain, causes memory changes, loss of body functions and erratic behavior. It slowly deteriorates the identity of the person you once knew and takes away the ability of them to connect with their loved ones. It becomes nearly impossible for them to walk, talk, or find familiarity in their once familiar surroundings. On top of all of this, no one has ever survived Alzheimer’s.
Myth Two: Typical aging includes memory loss
Fact: It is a true fact that as people age, they have occasional memory problems that are typically insignificant and do not affect their lives or day-to-day functioning. Alzheimer’s is much more than this. Alzheimer’s memory loss includes forgetting familiar friends and family or forgetting where you’ve lived for the past 30 years. Alzheimer’s memory loss also are a malfunction of brain cells which ultimately lead to brain cell deaths.
Myth Three: Only the elderly can have Alzheimer’s disease
Fact: People as young as 30 or 40 can be affected by Alzheimer’s disease. The name of this is younger-onset Alzheimer’s. It is estimated that about 200,000 people in the United States suffer from younger-onset Alzheimer’s disease.
Myth Four: Aspartame causes memory loss.
Fact: While Aspartame has been linked to many health problems over the years, a study that was conducted in 2006 canceled out any claims that Aspartame has any relation to Alzheimer’s disease.
Myth Five: There are treatments to stop Alzheimer’s disease
Fact: As of today, there is no known treatment to cure Alzheimer’s disease. There are some drugs that exist which slow down the worsening of symptoms of the disease, but they are only effective in about half of the users.